| Molecular and circulating biomarkers in patients with glioblastoma N Senhaji, A Squalli Houssaini, S Lamrabet, S Louati, S Bennis International Journal of Molecular Sciences 23 (13), 7474, 2022 | 32 | 2022 |
| New biomarkers and treatment advances in triple-negative breast cancer B El Hejjioui, S Lamrabet, S Amrani Joutei, N Senhaji, T Bouhafa, ... Diagnostics 13 (11), 1949, 2023 | 6 | 2023 |
| Clinical Evidence of Circulating Tumor DNA Application in Aggressive Breast Cancer B El Hejjioui, L Bouguenouch, MA Melhouf, H El Mouhi, S Bennis Diagnostics 13 (3), 470, 2023 | 3 | 2023 |
| Glioblastoma vaccines as promising immune-therapeutics: challenges and current status A Squalli Houssaini, S Lamrabet, JP Nshizirungu, N Senhaji, M Sekal, ... Vaccines 12 (6), 655, 2024 | 1 | 2024 |
| Prognostic value of ATRX and p53 status in high-grade glioma patients in Morocco AS Houssaini, S Lamrabet, N Senhaji, M Sekal, JP Nshizirungu, ... Cureus 16 (3), 2024 | 1 | 2024 |
| Immunohistochemical and molecular evaluation of idh in glioblastomas as prognostic marker in moroccan population AS Houssaini, S Lamrabet, N Senhaji, M Seka, B EL Hejjioui, M Karkour Teikyo Medical J 45, 7490-99, 2022 | 1 | 2022 |
| Evaluation of the proliferation marker Ki-67 and the IDH mutation in glioblastoma AS Houssaini, S Lamrabet, N Senhaji, M Sekal, M Karkouri, S Bennis EUROPEAN JOURNAL OF HUMAN GENETICS 32, 263-264, 2024 | | 2024 |